Indian Heparin Exporters: Complete Supplier Ranking with Market Share — 854 Manufacturers (2026) — TransData Nexus

Q: Who is the largest heparin buyer importing from India?

FRESENIUS KABI USA, LLC (UNITED STATES) is the largest heparin importer from India with a 12.8% market share and import value of $45.1M.

Q: How many heparin buyers import from India?

There are 854 active heparin buyers importing from India, with a combined import market of $352.8M across 4,586 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top heparin buyers from India?

The top 5 heparin buyers — FRESENIUS KABI USA, LLC, BOSTON ONCOLOGY ARABIA, NUEVOS ETICOS NEOETHICALS, S.A., EVERSANA, HOSPIRA INC — together control 45.5% of total heparin import value from India.

Suresh Sormare

Heparin

India Pharmaceutical Trade Intelligence

$352.8M391 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES42.1%India → SAUDI ARABIA12.3%

ImportsCHINA → India$508.4B BELGIUM → India$2.8B

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $148.5M through 913 shipments. This represents a market share of 42.1% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• FRESENIUS KABI USA, LLC - $45.1M (30.4% of country's total business)

• EVERSANA - $28.2M (19.0% of country's total business)

• HOSPIRA INC - $16.3M (11.0% of country's total business)

• FRESENIUS KABI USA LLC - $11.8M (7.9% of country's total business)

• MYLAN INSTITUTIONAL INC 2898 - $9.5M (6.4% of country's total business)

• Rest of United States's importers - $37.6M (25.3% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $162.6K, indicating premium pricing strategy compared to the market average of $76.9K.

United States is a key market for Heparin imports, representing 42.1% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Heparin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Indian heparin imports encompasses several key segments:

1. Distributors: Entities like EVERSANA (United States, $28.18M) and E U Pharmaceuticals Co., Ltd (Thailand, $7.84M) function as intermediaries, purchasing heparin in bulk to supply hospitals, clinics, and pharmacies. Their buying behavior is characterized by large, regular orders to maintain a steady supply chain.

2. Hospital Groups: Organizations such as Fresenius Kabi USA, LLC (United States, $45.10M) and Hospira Inc (United States, $16.34M) procure heparin directly for use within their healthcare facilities. Their purchasing patterns are driven by patient demand and treatment protocols, often resulting in consistent, sizable orders.

3. Government Procurement: While specific entities like UNICEF or national health ministries are not listed among the top buyers, government procurement plays a significant role in heparin distribution. These bodies typically engage in tender-based purchasing, emphasizing cost-effectiveness and supply reliability to meet public health needs.

4. Re-exporters: Companies such as Boston Oncology Arabia (Saudi Arabia, $42.14M) may act as re-exporters, importing heparin for distribution to neighboring regions. Their order sizes can vary, influenced by regional demand and trade agreements.

5. Contract Manufacturers: Entities like Mylan Institutional Inc (United States, $9.48M) may procure heparin as a raw material for producing finished pharmaceutical products. Their purchasing behavior is aligned with production schedules and market demand for heparin-based medications.

Each segment's procurement strategies are tailored to their operational needs, with factors such as regulatory compliance, market demand, and supply chain logistics influencing their order patterns.

Country-Specific Import Regulations

TransData Nexus Heparin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: Food and Drug Administration (FDA).

2. Import Registration Process for Heparin: Importers must submit analytical data with each shipment, including SAX-HPLC chromatograms and 1D-1H-NMR spectra, to ensure compliance with USP specifications and FDA standards.

3. Estimated Timeline for Registration: The FDA reviews import documentation on a case-by-case basis; timelines can vary depending on compliance and completeness of submissions.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this code are generally subject to a 0% import duty, but importers should verify current rates with U.S. Customs and Border Protection.

Saudi Arabia

1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

2. Import Registration Process for Heparin: Importers must register pharmaceutical products with the SFDA, providing comprehensive documentation on product quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and SFDA's review workload.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Saudi Arabia, but importers should confirm current rates with Saudi Customs.

Guatemala

1. Drug Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).

2. Import Registration Process for Heparin: Importers are required to submit product registration applications to MSPAS, including detailed information on product composition, manufacturing processes, and quality control measures.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the thoroughness of the application and MSPAS's review schedule.

Demand Drivers & Market Opportunity

TransData Nexus Heparin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for heparin in importing countries is primarily driven by the prevalence of cardiovascular diseases, which require anticoagulant therapy. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, underscoring the consistent need for heparin. Additionally, the inclusion of heparin in the WHO Model List of Essential Medicines highlights its critical role in healthcare systems worldwide. (who.int)

Government healthcare programs and the expansion of universal health coverage further bolster heparin demand. Many countries implement tender-based procurement systems to ensure the availability of essential medicines like heparin in public health facilities. For instance, centralized procurement arrangements have been shown to improve the distribution of essential medicines to primary care institutions, enhancing access and affordability. With 854 buyers across 137 countries, the global market for heparin presents substantial opportunities for suppliers to meet the ongoing and growing needs of diverse healthcare systems.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Heparin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest heparin buyer importing from India?

Based on import volume and value, FRESENIUS KABI USA, LLC (UNITED STATES) leads with $45.1M in imports and a 12.8% market share — the highest of any single heparin importer. BOSTON ONCOLOGY ARABIA (SAUDI ARABIA) and NUEVOS ETICOS NEOETHICALS, S.A. (GUATEMALA) are the next largest buyers.

QHow many companies buy heparin from India?

There are 854 active heparin buyers importing from India, with a combined market of $352.8M across 4,586 shipments to 137 countries. The top 5 buyers hold 45.5% of total import value, while the remaining 849 buyers handle the other 54.5%.

QWhich countries import the most heparin from India?

The top importing countries for heparin from India are United States (42.1%), Saudi Arabia (12.3%), Guatemala (8.7%), Thailand (7.8%), Philippines (4.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of heparin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for heparin from India?

The average import transaction value for heparin from India is $76.9K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Heparin buyer market intelligence

1Buyer Segment Analysis

The buyer landscape for Indian heparin imports encompasses several key segments:

Each segment's procurement strategies are tailored to their operational needs, with factors such as regulatory compliance, market demand, and supply chain logistics influencing their order patterns.

Country-Specific Import Regulations

TransData Nexus Heparin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA reviews import documentation on a case-by-case basis; timelines can vary depending on compliance and completeness of submissions.

Saudi Arabia

1. Drug Regulatory Authority: Saudi Food and Drug Authority (SFDA).

2. Import Registration Process for Heparin: Importers must register pharmaceutical products with the SFDA, providing comprehensive documentation on product quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the application and SFDA's review workload.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally exempt from import duties in Saudi Arabia, but importers should confirm current rates with Saudi Customs.

Guatemala

1. Drug Regulatory Authority: Ministry of Public Health and Social Assistance (MSPAS).

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months, subject to the thoroughness of the application and MSPAS's review schedule.

Demand Drivers & Market Opportunity

TransData Nexus Heparin buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Heparin

Heparin

Who Buys Heparin from India — 854 Importers Behind a $352.8M Market

Top Heparin Importers — Ranked by Import Value

Top Heparin Buyers & Importers

Related Analysis

Need Details?

Heparin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Heparin — and from which countries?

Heparin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Heparin Buyers & Importers

QWho is the largest heparin buyer importing from India?

QHow many companies buy heparin from India?

QWhich countries import the most heparin from India?

QWhat is the average import order value for heparin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Saudi Arabia

3Guatemala

4Thailand

5Philippines

Analysis Methodology